Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.

Yazar: Ellis, M N, Lobe, D C, Spector, T
Baskı/Yayın Bilgisi 1989

Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.

Yazar: Spector, T, Lobe, D C, Ellis, M N, Blumenkopf, T A, Szczech, G M
Baskı/Yayın Bilgisi 1992

Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1.

Yazar: Ellis, M N, Waters, R, Hill, E L, Lobe, D C, Selleseth, D W, Barry, D W
Baskı/Yayın Bilgisi 1989

UV inactivation of pathogenic and indicator microorganisms.

Yazar: Chang, J C, Ossoff, S F, Lobe, D C, Dorfman, M H, Dumais, C M, Qualls, R G, Johnson, J D
Baskı/Yayın Bilgisi 1985